1-O-{4-O-[3-(4-fluorophenyl)propyl]-alpha-D-galactosyl}-N-hexacosanoylphytosphingosine

Term ID

CHEBI:145516

Synonyms

(2S,3S,4R)-1-{4-O-[3-(4-fluorophenyl)propyl]-alpha-D-galactopyranosyloxy}-2-hexacosanoylaminooctadecane-3,4-diol
N-[(2S,3S,4R)-3,4-dihydroxy-1-({4-O-[3-(4-fluorophenyl)propyl]-alpha-D-galactopyranosyl}oxy)octadecan-2-yl]hexacosanamide
N-{(2S,3S,4R)-1-{4-O-[3-(4-fluorophenyl)propyl]-alpha-D-galactosyloxy}-3,4-dihydroxyoctadecan-2-yl}hexacosanamide

Definition

A glycophytoceramide having a 4-O-[3-(4-fluorophenyl)propyl]-alpha-D-galactosyl residue at the O-1 position and a hexacosanoyl group attached to the nitrogen. One of a series of an extensive set of 4"-O-alkylated alpha-GalCer analogues evaluated (PMID:30556652) as invariant natural killer T-cell (iNKT) antigens.

References

PMID:30556652

Ontology

ChEBI ( EBI )

Relationships

is a type of: glycophytoceramide

glycophytoceramide Show first 5 Terms
has_functional_parent: alpha-D-galactose

alpha-D-galactose Show first 5 Terms

Phenotype

Phenotype resulting from 1-O-{4-O-[3-(4-fluorophenyl)propyl]-alpha-D-galactosyl}-N-hexacosanoylphytosphingosine

Phenotype where environments contain 1-O-{4-O-[3-(4-fluorophenyl)propyl]-alpha-D-galactosyl}-N-hexacosanoylphytosphingosine

Phenotype modified by environments containing 1-O-{4-O-[3-(4-fluorophenyl)propyl]-alpha-D-galactosyl}-N-hexacosanoylphytosphingosine

Human Disease Model